Progress in antenatal magnesium sulfate exposure for neuroprotection in preterm infants
10.3760/cma.j.cn113903-20220509-00452
- VernacularTitle:产前硫酸镁治疗保护早产儿神经系统的临床应用研究进展
- Author:
Mengtong LIU
1
;
Huixia YANG
Author Information
1. 北京大学第一医院妇产科，北京 100034
- Keywords:
Magnesium sulfate;
Neuroprotective agents;
Infant, premature, diseases;
Nervous system diseases;
Neuroprotection;
Fetal therapies
- From:
Chinese Journal of Perinatal Medicine
2023;26(1):68-71
- CountryChina
- Language:Chinese
-
Abstract:
Magnesium sulfate has been administered to pregnant women at imminent risk of preterm delivery for fetal neuroprotection, but its adverse effects and target population have not been fully studied. This paper summarizes the current protocols according to the existing guidelines and the latest research progress, including the gestational age at intervention, dose, duration of therapy and the need for re-administration, hoping to provide a reference for the clinical use of magnesium sulfate for fetal neuroprotection in China.
